Guardant HealthGH
NASDAQMedical Laboratories
$175.00-0.01%
No cached AI snapshot yet for GH.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
$11.85BMarket cap
$120.7452-week high
$36.3652-week low
2,065,488Avg volume (30d)
2,506 employees131.17M shares outstandinglisted 2018-10-04
Next earnings ~May 5, 2026
About Guardant Health
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Latest News
Cathie Wood’s ARK buys Guardant Health stock, sells Iridium
Guardant Health, Inc. (GH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Guardant Health CIO Kumud Kalia sells $632k in stock
Euro: Firm Dollar keeps pressure on Euro before FOMC - Danske Bank
FOMC day
Bitcoin retreats after crypto bill setback, Fed next
Related Stocksin Medical Laboratories
Ready to see the live AI view on GH?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing GH side-by-side with live signals.